{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28177533",
  "DateCompleted": {
    "Year": "2017",
    "Month": "09",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2017",
    "Month": "09",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2017",
        "Month": "02",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1002/pd.5021"
    ],
    "Journal": {
      "ISSN": "1097-0223",
      "JournalIssue": {
        "Volume": "37",
        "Issue": "4",
        "PubDate": {
          "Year": "2017",
          "Month": "Apr"
        }
      },
      "Title": "Prenatal diagnosis",
      "ISOAbbreviation": "Prenat Diagn"
    },
    "ArticleTitle": "Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy.",
    "Pagination": {
      "StartPage": "375",
      "EndPage": "382",
      "MedlinePgn": "375-382"
    },
    "Abstract": {
      "AbstractText": [
        "Mothers carrying anti-Ro antibodies are frequently referred for weekly echocardiograms to early detect and treat antibody-mediated fetal heart disease. We tested a surveillance strategy based on anti-Ro antibody titers.",
        "From 2009 to 2014, 232 pregnancies were referred for maternal anti-Ro antibodies. At the baseline echocardiogram, anti-Ro titers were measured by enzyme-linked immunosorbent essay and results categorized as negative (<8\u2009U/mL; n\u2009=\u200943; excluded), low-moderate positive (8-49\u2009U/mL; n\u2009=\u200962; group 1) or high positive (50 - >100\u2009U/mL; n\u2009=\u2009127; group 2). Serial echocardiograms to \u226524\u2009weeks were only recommended for group 2 mothers.",
        "Group 1 patients underwent significantly less fetal echocardiograms when compared with group 2 mothers (median 2 vs. 4; p\u2009<\u20090.001). Isolated endocardial fibroelastosis (n\u2009=\u20091) and incomplete (n\u2009=\u20094) or complete (n\u2009=\u20094) heart block were diagnosed in 9 (8%) pregnancies with anti-Ro titers >100\u2009U/mL but none with lower titers (odds ratio 17.78; p\u2009=\u20090.004). Incomplete block and endocardial fibroelastosis regressed with transplacental corticosteroid and immune globulin therapy.",
        "Limiting serial fetal echocardiograms to women with high anti-Ro antibody levels is safe and more cost effective. While numbers of echocardiograms were significantly reduced in referrals with anti-Ro titers <50\u2009U/mL, reversible abnormalities with prenatal treatment were detected by serial echocardiography in group 2 patients. \u00a9 2017 John Wiley & Sons, Ltd."
      ],
      "CopyrightInformation": "\u00a9 2017 John Wiley & Sons, Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fetal Cardiac Program, Labatt Family Heart Centre, Hospital for Sick Children, University of Toronto, Toronto, Canada."
          }
        ],
        "LastName": "Kan",
        "ForeName": "Nobuhiko",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology, Hospital for Sick Children, University of Toronto, Toronto, Canada."
          }
        ],
        "LastName": "Silverman",
        "ForeName": "Earl D",
        "Initials": "ED"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada."
          }
        ],
        "LastName": "Kingdom",
        "ForeName": "John",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fetal Cardiac Program, Labatt Family Heart Centre, Hospital for Sick Children, University of Toronto, Toronto, Canada."
          }
        ],
        "LastName": "Dutil",
        "ForeName": "Nathalie",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Canada."
          }
        ],
        "LastName": "Laskin",
        "ForeName": "Carl",
        "Initials": "C"
      },
      {
        "Identifier": [
          "0000-0002-9012-6592"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fetal Cardiac Program, Labatt Family Heart Centre, Hospital for Sick Children, University of Toronto, Toronto, Canada."
          }
        ],
        "LastName": "Jaeggi",
        "ForeName": "Edgar",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Prenat Diagn",
    "NlmUniqueID": "8106540",
    "ISSNLinking": "0197-3851"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunologic Factors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Echocardiography"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Endocardial Fibroelastosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Fetal Diseases"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Fetal Monitoring"
    },
    {
      "QualifierName": [
        "congenital",
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Heart Block"
    },
    {
      "QualifierName": [
        "congenital",
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Heart Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "congenital",
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Immune System Diseases"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Immunologic Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Ultrasonography, Prenatal"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}